abstract |
There is provided a compound of formula (I) or a pharmaceutically acceptable salt, solvate or ester in vivo, pharmaceutically acceptable thereof and pharmaceutical compositions comprising these, all for use in the treatment of chemokine-mediated diseases and disorders. |